Boyang Cheng
Ningbo, 315832, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Reshape the Fates of Treg and CD8+T Cells Through IL-2Rα by Synergizing Divergent Receptor-Biased IL-2 PEGylates.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 14, 2024
Author Correction: An engineered influenza virus to deliver antigens for lung cancer vaccination.
Journal: Nature biotechnology
Published: July 14, 2023
Synthesis of Novel Pentacyclic Triterpenoid Derivatives that Induce Apoptosis in Cancer Cells through a ROS-dependent, Mitochondrial-Mediated Pathway.
Journal: Molecular pharmaceutics
Published: December 02, 2022
Discovery of Pentacyclic Triterpenoid PROTACs as a Class of Effective Hemagglutinin Protein Degraders.
Journal: Journal of medicinal chemistry
Published: May 17, 2022
An engineered influenza virus to deliver antigens for lung cancer vaccination.
Journal: Nature biotechnology
Published: March 26, 2022
Proximity-enabled covalent binding of IL-2 to IL-2Rα selectively activates regulatory T cells and suppresses autoimmunity.
Journal: Signal transduction and targeted therapy
Published: January 16, 2022
Intelligent Nanodelivery System-Generated 1 O2 Mediates Tumor Vessel Normalization by Activating Endothelial TRPV4-eNOS Signaling.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: January 03, 2022
Efficient Inhibition of SARS-CoV-2 Using Chimeric Antisense Oligonucleotides through RNase L Activation*.
Journal: Angewandte Chemie (International ed. in English)
Published: May 02, 2021
Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells.
Journal: Nature biomedical engineering
Published: June 08, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026